Literature DB >> 32598468

Electronically Monitored Nicotine Gum Use Before and After Smoking Lapses: Relationship With Lapse and Relapse.

Tanya R Schlam1,2, Timothy B Baker1,3, Stevens S Smith1,3, Daniel M Bolt4, Danielle E McCarthy1,3, Jessica W Cook1,3,5, Todd Hayes-Birchler1, Michael C Fiore1,3, Megan E Piper1,3.   

Abstract

INTRODUCTION: Greater use of nicotine replacement therapy (NRT) is related to smoking cessation success, but the causal direction is unclear. This study characterized the relationship between NRT use and smoking lapse and relapse.
METHODS: Participants (N = 416 smokers; 57% female, 85% White) were recruited from primary care for a smoking cessation factorial experiment and analyzed if abstaining ≥1 day in the first 2 weeks post-target quit day (TQD). Participants were randomized to counseling and 8 versus 26 weeks of nicotine patch plus nicotine gum post-TQD. Participants carried electronic dispensers that timestamped each gum use. Participants who lapsed (smoked after abstaining) within 6 weeks post-TQD were matched with nonlapsers (n = 146 pairs) on multiple variables. We compared lapsers' versus matched nonlapsers' gum use in the 5 days before and after the lapsers' first lapse.
RESULTS: By week 6 post-TQD, 63% of participants lapsed. Compared with nonlapsers, lapsers used less gum 1 and 2 days pre-"lapse" and on the 5 days post-lapse. Lapsers used less gum during the 5 days post-lapse than the 5 days pre-lapse. Univariate survival analyses with lapsers showed greater gum use during both pre- and post-lapse periods predicted longer latency to relapse in the first 6 weeks.
CONCLUSIONS: In a smoking cessation attempt using nicotine patch plus gum, lapsers versus matched nonlapsers used less gum immediately preceding and following their first lapse. Lower mean gum use before and after lapses predicted a more rapid escalation to relapse. Decreased nicotine gum use both precedes and follows returns to smoking during cessation attempts. IMPLICATIONS: This research examined electronically monitored nicotine gum use collected in real time and found that among smokers engaged in a quit attempt, lapsers (vs. matched nonlapsers) tended to decrease their gum use 1-2 days prior to lapsing and to further decrease their gum use from pre- to post-lapse. Decreased gum use pre-lapse may signal heightened lapse risk in 1-2 days, with lower level of gum use predicting a more precipitous course of relapse. These results encourage further exploration of objective measures of smoking medication use patterns to examine their signaling properties and to inform understanding of cessation failure. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov NCT01120704.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved.For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32598468      PMCID: PMC7593353          DOI: 10.1093/ntr/ntaa116

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  29 in total

1.  Measuring medication adherence: are missed doses reported more accurately then perfect adherence?

Authors:  G J Wagner; J G Rabkin
Journal:  AIDS Care       Date:  2000-08

2.  Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation.

Authors:  Tai-Hing Lam; Abu Saleh M Abdullah; Sophia S C Chan; Anthony J Hedley
Journal:  Psychopharmacology (Berl)       Date:  2004-07-29       Impact factor: 4.530

3.  Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.

Authors:  Saul Shiffman; Christine T Sweeney; Stuart G Ferguson; Mark A Sembower; Joseph G Gitchell
Journal:  Clin Ther       Date:  2008-10       Impact factor: 3.393

Review 4.  A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success.

Authors:  Tobias Raupach; Jamie Brown; Aleksandra Herbec; Leonie Brose; Robert West
Journal:  Addiction       Date:  2013-09-13       Impact factor: 6.526

5.  Interventions to increase adherence to medications for tobacco dependence.

Authors:  Gareth J Hollands; Felix Naughton; Amanda Farley; Nicola Lindson; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2019-08-16

6.  Predicting smoking cessation. Who will quit with and without the nicotine patch.

Authors:  S L Kenford; M C Fiore; D E Jorenby; S S Smith; D Wetter; T B Baker
Journal:  JAMA       Date:  1994-02-23       Impact factor: 56.272

7.  Use of more nicotine lozenges leads to better success in quitting smoking.

Authors:  Saul Shiffman
Journal:  Addiction       Date:  2007-05       Impact factor: 6.526

8.  Implementing a hospital-based smoking cessation programme: evidence for a learning effect.

Authors:  Tobias Raupach; Lion Shahab; Karin Neubert; Dorothea Felten; Gerd Hasenfuss; Stefan Andreas
Journal:  Patient Educ Couns       Date:  2007-11-26

9.  The Wisconsin Predicting Patients' Relapse questionnaire.

Authors:  Daniel M Bolt; Megan E Piper; Danielle E McCarthy; Sandra J Japuntich; Michael C Fiore; Stevens S Smith; Timothy B Baker
Journal:  Nicotine Tob Res       Date:  2009-04-16       Impact factor: 4.244

10.  Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum.

Authors:  Ned L Cooney; Judith L Cooney; Bridget L Perry; Michael Carbone; Emily H Cohen; Howard R Steinberg; David T Pilkey; Kevin Sevarino; Cheryl A Oncken; Mark D Litt
Journal:  Addiction       Date:  2009-06-22       Impact factor: 6.526

View more
  1 in total

1.  Daily use of nicotine replacement medications is related to daily smoking status: An ecological momentary assessment study.

Authors:  Emily T Hébert; Tanushri Bhushan; Chaelin K Ra; Summer Frank-Pearce; Adam C Alexander; Ashley B Cole; Darla E Kendzor; Michael S Businelle
Journal:  Drug Alcohol Depend       Date:  2021-10-29       Impact factor: 4.492

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.